Biotricity delivers Bioheart, a groundbreaking consumer Heart Monitor

REDWOOD CITY, Calif., Nov 10, 2021 (BUSINESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) a modern medical technology company focused on delivering innovative, remote biometric…

A graph showing an upward trend.

Biotricity releases fiscal 2022 second quarter financial results

REDWOOD CITY, Calif., Nov 04, 2021 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) a medical diagnostic and consumer healthcare technology company, today announced financial results…

Second quarter update

Biotricity to report second quarter fiscal 2022 financial results on November 4, 2021

REDWOOD CITY, Calif., Nov 02, 2021 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) a medical diagnostic and consumer healthcare technology company, today announced that it will…

Biotricity launches Biocare Cardiac application for Samsung’s Galaxy Watch4 series

REDWOOD CITY, Calif., Oct 07, 2021 (ACCESSWIRE) -- Biotricity, Inc. (NASDAQ:BTCY), a medical diagnostic and consumer healthcare technology company, today announced the upcoming…

Biotricity NASDAQ Open Bell

Remote medical diagnostic company, Biotricity, to ring the Nasdaq stock market opening bell on Thursday, October 7th

REDWOOD CITY, Calif., Oct 06, 2021 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) a medical diagnostic and consumer healthcare technology company, today announced it will be…

Oppenheimer Summit

Biotricity to discuss expansion of remote monitoring medical device products at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on September 22nd

REDWOOD CITY, Calif., Sep 21, 2021 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) a medical diagnostic and consumer healthcare technology company, today announced that its Chief…

Biokit

Biotricity unveils “Biokit” with 3 personal medical devices to expand into cardiac disease management

REDWOOD CITY, Calif., Sep 14, 2021 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) a medical diagnostic and consumer healthcare technology company, today announced that it has…

Biotricity glyph with the word

Biotricity announces closing of exercise of underwriter’s option to purchase additional common stock

REDWOOD CITY, Calif., Sep 13, 2021 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) a medical diagnostic and consumer healthcare technology company, today announced that the…

Biotricity glyph and upwards arrow signifying growth

Biotricity to discuss sales expansion, recent financing, and wearable medical device portfolio expansion at H.C. Wainwright Conference

REDWOOD CITY, Calif., Sep 08, 2021 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…

nasdaq

Biotricity completes Nasdaq listing

REDWOOD CITY, Calif., Aug 30, 2021 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY), a medical diagnostic and consumer healthcare technology company, today announced the closing of…

Nasdaq

Biotricity prices $15 million underwritten public offering of common stock and listing on the Nasdaq capital market

REDWOOD CITY, Calif., Aug 26, 2021 (ACCESSWIRE) -- Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced the pricing of…

Growth chart

Biotricity announces proposed underwritten public offering of common stock in connection with expected Nasdaq listing

REDWOOD CITY, Calif., Aug 25, 2021 (ACCESSWIRE) -- Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it intends…